Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9
- PMID: 10696124
- DOI: 10.1002/(sici)1096-911x(200003)34:3<183::aid-mpo4>3.0.co;2-o
Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: report of the international society of paediatric oncology (SIOP) nephroblastoma trial and study 9
Abstract
Background: The SIOP Nephroblastoma therapeutic protocols include a period of preoperative chemotherapy followed by nephrectomy and a period of postoperative chemotherapy. From the outset, identification of low-risk groups has been an aim of the SIOP Nephroblastoma Trials and Studies. Now that 90% of children with Wilms tumor can be cured, attention is even more focused on the identification of patients who could benefit from less aggressive postoperative therapy, thus minimizing the morbidity and late effects associated with treatment. The prognostic implications of total necrosis in nephroblastoma after chemotherapy have not been investigated hitherto.
Procedure: Between November 1, 1987 and June 30, 1993, 599 patients referred to the SIOP-9 Nephroblastoma Trial and Study were preoperatively treated and classified as stages I-IV nonanaplastic Wilms tumor.
Results: Of these 599 patients, pathologic examination of the nephrectomy specimen revealed a completely necrotic Wilms tumor (CNWT) with no viable tumor remaining in 59 (10%): these comprised 37 stages I-III and 22 stage IV. Of these patients, 58 (98%) had no evidence of disease at 5 years vs. 90% for the rest of the cohort (P < 0.05). Stages I-III patients represented 63% of CNWT and had a 97% overall survival rate. The only death was related to veno-occlusive disease and occurred in a stage I patient in the month following nephrectomy. Stage IV patients represented 37% of CNWT (vs. only 10% of all other cases of unilateral nonanaplastic Wilms tumor) and had a 100% rate of survival. Children with CNWT were older (mean 59 months vs. 43 months); their tumor at diagnosis was larger and had regressed more significantly at subsequent ultrasound examination. The data also uphold the hypothesis that Wilms tumors of blastemic pattern are most aggressive, but also are extremely responsive to chemotherapy.
Conclusions: Patients with unilateral nonanaplastic WT that showed total necrosis following preoperative chemotherapy had excellent outcome and should benefit from less aggressive postoperative treatment in further trials. Other very responsive tumors, such as Wilms with <10% viable tumor, should also be assessed.
Similar articles
-
[Renal neoplasms in children].Przegl Lek. 2004;61 Suppl 2:20-3. Przegl Lek. 2004. PMID: 15686041 Polish.
-
Results of the SIOP 93-01/GPOH trial and study for the treatment of patients with unilateral nonmetastatic Wilms Tumor.Klin Padiatr. 2004 May-Jun;216(3):132-40. doi: 10.1055/s-2004-822625. Klin Padiatr. 2004. PMID: 15175957 Clinical Trial.
-
Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.Pol J Pathol. 2011;62(2):84-8. Pol J Pathol. 2011. PMID: 21866463
-
Optimal neoadjuvant chemotherapy duration in Wilms tumour with intravascular thrombus: A literature review and evidence from SIOP WT 2001 trial.Pediatr Blood Cancer. 2019 Nov;66(11):e27930. doi: 10.1002/pbc.27930. Epub 2019 Jul 24. Pediatr Blood Cancer. 2019. PMID: 31339231
-
The role of preoperative chemotherapy in the management of Wilms' tumor. The SIOP studies. International Society of Pediatric Oncology.Urol Clin North Am. 2000 Aug;27(3):443-54. doi: 10.1016/s0094-0143(05)70092-6. Urol Clin North Am. 2000. PMID: 10985144 Review.
Cited by
-
Is the SIOP-2001 Classification of Renal Tumors of Childhood accurate with regard to prognosis? A problem revisited.Arch Med Sci. 2012 Sep 8;8(4):684-9. doi: 10.5114/aoms.2012.30292. Arch Med Sci. 2012. PMID: 23056081 Free PMC article.
-
Efficacy of Preoperative Chemotherapy in Treatment of Children With Wilms' Tumor: A Meta-Analysis.Iran J Pediatr. 2015 Apr;25(2):e366. doi: 10.5812/ijp.366. Epub 2015 Apr 18. Iran J Pediatr. 2015. PMID: 26196000 Free PMC article.
-
Role of MRI in the management of patients with nephroblastoma.Eur Radiol. 2008 Apr;18(4):683-91. doi: 10.1007/s00330-007-0826-4. Epub 2008 Jan 12. Eur Radiol. 2008. PMID: 18193429 Review.
-
Current management of wilms' tumor.Curr Urol Rep. 2010 Feb;11(1):58-65. doi: 10.1007/s11934-009-0082-z. Curr Urol Rep. 2010. PMID: 20425639 Review.
-
Histological features of primary tumors after induction or high-dose chemotherapy in high-risk neuroblastoma.Pediatr Surg Int. 2014 Sep;30(9):919-26. doi: 10.1007/s00383-014-3564-0. Epub 2014 Jul 27. Pediatr Surg Int. 2014. PMID: 25064228
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical